Regulator Helplines, “Super” Intelligence Plans, Overton Out at FDA
In this week’s Pathways Picks: New consultation services in China, Finland, and Norway; CMS and FDA talk “super” intelligence (that is, AI); White House drops Heidi Overton as FDA commissioner nominee; CMS targets fraud and abuse; Germany addresses medical equipment contracts; Hong Kong eyes mandatory device regulations; and more medtech policy updates.